Search

Search Constraints

You searched for: Author/Creator Camino, Manuela

Search Results

1. "First-In-Human" Clinical Trial Employing Adoptive Transfer of Autologous Thymus-Derived Treg Cells (thyTreg) to Prevent Graft Rejection in Heart-Transplanted Children. (July 2018)

2. "FIRST-IN-HUMAN" CLINICAL TRIAL EMPLOYING ADOPTIVE TRANSFER OF AUTOLOGOUS THYMUS-DERIVED TREG CELLS (THYTREG) TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN. Issue 3 (September 2020)

3. 213.2: Preliminary Results of the First Clinical Trial to Prevent Graft Rejection in Heart Transplant Children Employing a Cellular Therapy With Autologous Treg Obtained From Thymic Tissue (thyTreg). (13th September 2022)

4. 213.2: Preliminary Results of the First Clinical Trial to Prevent Graft Rejection in Heart Transplant Children Employing a Cellular Therapy With Autologous Treg Obtained From Thymic Tissue (thyTreg). (13th September 2022)

5. Behavioral economics—A framework for donor organ decision‐making in pediatric heart transplantation. (27th January 2020)

6. Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart‐transplant children: A delicate balance between risk of rejection or atopic symptoms. Issue 5 (25th January 2019)

7. Induction Therapy With Basiliximab in Heart-Transplanted Children Impairs Regulatory T-Cell Population (Treg): effects on frequency, phenotype and Foxp3 expression. (May 2017)

8. Malignancy following heart transplantation: differences in incidence and prognosis between sexes – a multicenter cohort study. (12th March 2021)

9. Pharmacokinetics of tacrolimus granules in pediatric de novo liver, kidney, and heart transplantation: The OPTION study. (21st January 2019)